GCAC and Genetica Finalize Definitive Agreement to Provide Best in Class Cannabis Recommendations for Canadian Veterans

Vancouver, British Columbia, Canada - September 20, 2022 – Global Compliance Applications Corp. ("GCAC" or the "Company") (CSE:APP), (FSE:2FA), (OTC:FUAPF), a leading medical cannabis chain-of-custody compliance and data platform announce that Genetica LLC  (“Genetica”) and GCAC have executed a Definitive Agreement to develop new data insights and better product recommendations to the Canadian Veteran consumer.  This initiative is part of GCAC’s plan to launch this Fall a Canadian non-possession medical license store front called Citizen Green [1] 

Genetica is home to Flora AI™, the first Artificial Intelligence of its kind for cannabis-derived products. Flora AI represents a data pool of over 650 million sources utilized in real time to scientifically select the best product recommendations for individual consumers.

On June 3, 2022, GCAC and Genetica agreed to a Trade Agreement for the initial data to be valued at USD$120,000 to each party [2]. The finalization of the partnership will enable both parties to develop a strategic licensing plan to analyze anonymized, jointly transaction-level data to improve recommendations at both ends of the supply chain. This initiative will focus on retail opportunities in the United States and Canada, starting with GCAC’s offering to Canadian military veterans.

GCAC will be making available data collected from its technologies, Efixii, clearESG and Prescriptii, that will be used by partner LPs to track the cannabis from seedling to harvest. Genetica will provide over 100 million data points to be combined with Prescriptii's data [3] to launch the veteran's storefront. In addition, as more veterans use Citizen Green, Efixii will add cultivation and their feedback data to this stack. The partnership could see the data points increase to over 600 million within 90 days.

Richard Neal, Genetica Chief Science Officer, “As an industry, retailers recognize the importance of better educating the patient/consumer. We are past the legacy marketing points of either Sativa or Indica. By working with GCAC, we will improve our recommendations by including intel from the source of the product journey and consumer feedback in real-time. This partnership creates a new frontier of true cannabis knowledge.”

GCAC CEO Bradley Moore commented, “The Efixii Blockchain will provide a firehose of new data from everything on how the plant was grown, cared for, and finally harvested.  This data will be processed with Flora AI to provide the consumer with great insight.  As a veteran myself, I believe that vets want to not only understand this cannabis journey but also, more importantly, know how to create a path to long-term wellness”.

[1] https://newsroom.cannappscorp.com/215340-gcac-and-cultivator-joining-forces-to-provide-efixii-cultivated-cannabis-to-canadian-veterans

[2] https://newsroom.globalcompliance.app/216072-gcac-and-genetica-new-data-sharing-partnership-to-provide-best-in-class-recommendations-for-retail-cannabis-consumers

[3] https://newsroom.globalcompliance.app/203742-global-cannabis-releases-prescriptii-patient-portal

About Genetica

Genetica offers an interface, Flora AI, for both consumers and budtenders that merges data science and AI to predict which cannabis/hemp products will perform best for each individual, based on their needs and desires. By removing brand and product bias from the recommendations given to consumers, Genetica has created the first interface that goes far, far beyond a simple matching algorithm to give consumers the transparency and confidence they deserve when purchasing these products.

About Global Cannabis Applications Corp. “GCAC”

GCAC is a global leader in designing and developing innovative blockchain technologies and machine learning solutions to improve real-world businesses. GCAC's leading solution is Efixii, an Ethereum Layer 2 blockchain and EVM programming functionality that is on par with other Layer-2's, such as Polygon. GCAC can quickly connect each participant from product producers, distributors, manufacturers and retailers through a series of value chain dApps that allows for data connectivity to drive better consumer experiences and sales. GCAC created clearESG to assist businesses in communicating their sustainability goals and earned attributes on the blockchain through a series of ESG (Environmental, Social & Governance) merit badges. As an interconnected supply chain solution, the Efixii solution pays tokens for attesting to a product's value, or truthness, through a reward program. GCAC works in many agricultural industries providing a value-added blockchain offering through a cost-effective SaaS licensing model.

For more Company information, please visit www.cannappscorp.com, or review its profiles on www.sedar.com and on the Canadian Securities Exchange's website www.thecse.com.

GCAC Press Contact 

Phone: +1 (800) 409-5679 

Email: info@gcac.tech 

www.globalcompliance.app

Genetica Press Contact

Chloe Austin 785.341.1605

chloe@hiddenstreetmarketing.com

www.GetGenetica.com

Forward-Looking Information 

This news release may include forward-looking information within the meaning of Canadian securities legislation concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.

###